1. Home
  2. INVZ vs FHTX Comparison

INVZ vs FHTX Comparison

Compare INVZ & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innoviz Technologies Ltd. Ordinary shares

INVZ

Innoviz Technologies Ltd. Ordinary shares

HOLD

Current Price

$1.30

Market Cap

273.5M

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$4.37

Market Cap

246.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVZ
FHTX
Founded
2016
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.5M
246.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
INVZ
FHTX
Price
$1.30
$4.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$3.10
$11.86
AVG Volume (30 Days)
5.0M
190.5K
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,442,000.00
$24,518,000.00
Revenue This Year
$146.75
$47.50
Revenue Next Year
$53.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.09
N/A
52 Week Low
$0.48
$2.95
52 Week High
$3.14
$6.79

Technical Indicators

Market Signals
Indicator
INVZ
FHTX
Relative Strength Index (RSI) 38.40 47.08
Support Level $1.24 $4.33
Resistance Level $1.38 $4.82
Average True Range (ATR) 0.09 0.32
MACD 0.03 -0.03
Stochastic Oscillator 59.62 10.15

Price Performance

Historical Comparison
INVZ
FHTX

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: